C. Leteur

The Aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe

P. Opolon, J. Bourhis, G. Kroemer, 2009, Cell cycle.

Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat

E. Deutsch, J. Perfettini, S. Depil, 2017, Oncotarget.

NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy

E. Solary, F. Rosselli, E. Deutsch, 2017, Cell Death and Differentiation.

MBNL‐dependent impaired development within the neuromuscular system in myotonic dystrophy type 1

C. Legay, D. Furling, A. González-Barriga, 2022, Neuropathology and applied neurobiology.

CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis

J. Concordet, D. Furling, C. Pinset, 2021, Human molecular genetics.

Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination

J. Bourhis, J. Calderaro, J. Soria, 2010, Molecular Cancer Therapeutics.

[Pharmacological targeting of Mdm2: rationale and perspectives for radiosensitization].

Cyrus Chargari, J. Bourhis, C. Ferté, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiosensitization by Chir-124, a selective Chk1 inhibitor: Effects of p53 and cell cycle checkpoints

J. Bourhis, G. Kroemer, R. Golsteyn, 2009, Cell cycle.

NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy

E. Solary, F. Rosselli, F. Milliat, 2017, Cell Death and Differentiation.

Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts.

Cyrus Chargari, J. Bourhis, M. Janicot, 2011, Cancer letters.